About
Pharmaceuticals
Quark Pharmaceuticals, Inc. is a late clinical-stage pharmaceutical company, a leader in the discovery and development of novel RNAi-based therapeutics for unmet medical needs. Two products, which were granted Orphan designation, QPI -1002 and QP -1007 are in global phase III pivotal clinical studies for Delayed Graft Function (DGF) and Non Arteritic Ischemic Optic Neuropathy (NAION) respectively. QBI Enterprises Ltd is Quark'sIsraeli research and developmentcenter.QBI has a fully integrated drug development platform thatspans from therapeutic target identification to drug development.
Identity
| Name | Quark Pharmaceuticals |
|---|---|
| Slug | quark-pharmaceuticals |
| Type / kind | multinational |
| Crunchbase ID | quark-pharmaceuticals |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwIqBtIkJDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, May 2022 ceased to operate in israel |
| Last update | 2026-05-17 |
Location
| HQ country | United States |
|---|---|
| HQ country code | US |
| HQ address | 7999 Gateway Boulevard, Newark, CA, USA |
Web & social
| Website | http://quarkpharma.com/ |
|---|---|
| https://www.linkedin.com/company/35456903 | |
| Twitter / X | https://twitter.com/quarkpharma |
| https://www.facebook.com/QuarkPharma |
Classifications
Tags
pharmaceuticalsglaucomadegenerative-diseasesdiabetesdrug-development
Funding
| Total raised | — |
|---|
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}